BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33334785)

  • 1. Overexpression of Sine Oculis Homeobox Homolog 2 Predicts Poor Survival and Clinical Parameters of Patients with Colon Adenocarcinoma.
    Jiang Y; Zhou B; Liang B; Zeng F; Zou Z
    Ann Clin Lab Sci; 2020 Nov; 50(6):717-725. PubMed ID: 33334785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of homeobox B2 predicts poor survival of colon adenocarcinoma by enhancing tumor proliferation and invasion.
    Li S; Wang Y; Xuan Z; Zhang Y; Miao Z
    Ir J Med Sci; 2023 Feb; 192(1):89-97. PubMed ID: 35320486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
    Ren Y; Lv Y; Li T; Jiang Q
    Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu L; Jia S; Jin X; Zhu S; Zhang S
    DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
    Xiao J; Liu Q; Wu W; Yuan Y; Zhou J; Shi J; Zhou S
    Bioengineered; 2021 Dec; 12(1):4620-4632. PubMed ID: 34320917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma.
    Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
    Du J
    Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
    Huang X; Cao Y; Bao P; Zhu B; Cheng Z
    Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
    Zhao H; Liu G; Li Y; Yang N; Zhao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
    Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
    Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
    Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
    Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
    Lin Y; Li Y; Chen Y; Zhang Z
    Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
    Dang W; Zhu Z
    J Gene Med; 2020 Jul; 22(7):e3183. PubMed ID: 32159255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
    Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
    Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.